INTERNATIONAL PATENT: ASGARD THERAPEUTICS AB FILES APPLICATION FOR "TRANSCRIPTION FACTORS AND REPROGRAMMING MODULATORS FOR REPROGRAMMING CELLS TO CDC1 CELLS, COMPOSITIONS AND METHODS THEREOF"

GENEVA, Jan. 5 -- ASGARD THERAPEUTICS AB (Medicon Village223 81 Lund) filed a patent application (PCT/EP2025/067893) for "TRANSCRIPTION FACTORS AND REPROGRAMMING MODULATORS FOR REPROGRAMMING CELLS TO CDC1 CELLS, COMPOSITIONS AND METHODS THEREOF" on Jun 25, 2025. With publication no. WO/2026/003067, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROSA, Fabio Alexandre Fiuza (Rua do Brejo ndegree53Touria, Pousos2410-205 Leiria), PIRES, Cristiana Ferreira (Rua Fonte do Areeiro n293770-352 Palhaca), PEREIRA, Carlos Filipe Rib...